Chronic inflammation not only reduces the production of EPO, but can also generate resistance to its action, which compromises the bone marrow's ability to produce red blood cells, even in the presence of normal levels of EPO, contributing to the existence of anaemia, regardless of the role of hepcidin [16, 32, 37, 38]. Here, EPO is linked to anemia (phenotype).